Princeton, United States
MAIA Pharmaceuticals is a specialty pharmaceutical company headquartered in Princeton, New Jersey, USA. Established in 2013, the company is dedicated to the acquisition, development, and commercialization of niche generic products with a focus on injectables, diagnostics, hormones, and oncology.
With a proven track record in the Biopharma and Pharmaceutical industries, MAIA Pharmaceuticals leverages strategic supply chain partnerships and regulatory expertise to commercialize FDA-approved injectable and specialty products across U.S. hospital and specialty channels. The company's strategic approach includes internal drug development, targeted in-licensing, and capital-efficient commercialization practices.
The last investment round, a Seed Round of $845.00K, dates back to October 29, 2014. As MAIA Pharmaceuticals continues to expand its portfolio and build strategic global partnerships, it positions itself as a key player poised for sustainable long-term growth in the specialty pharma sector.
